Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001069530-21-000035
Filing Date
2021-06-14
Accepted
2021-06-14 16:22:47
Documents
1
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form3.html 3  
1 PRIMARY DOCUMENT certent-form3.xml 3 2201
  Complete submission text file 0001069530-21-000035.txt   3671
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 MARGALITA DRIVE SAN RAFAEL CA 94901
Business Address
Barry Richard (Reporting) CIK: 0001562371 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29959 | Film No.: 211014859